Department of Internal medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
Gastrointest Endosc. 2018 Jul;88(1):119-127.e4. doi: 10.1016/j.gie.2018.02.040. Epub 2018 Mar 3.
The aim of this study was to examine the prospective association between visceral obesity and the incidence and recurrence of colorectal adenoma.
We conducted a cohort study involving 2244 participants between 2006 and 2007. The study participants were prospectively followed until 2014 according to the initial colonoscopy and histopathology findings. Incident and recurrent colorectal adenoma groups were defined as individuals with a positive follow-up colonoscopy result from the normal results and adenoma groups, respectively, at the baseline colonoscopy.
Among the 1163 patients (51.8%) who received a follow-up colonoscopy, 509 (43.8%) and 654 (56.2%) were grouped into the normal and adenoma cohorts. Colorectal adenomas occurred in 592 patients (50.9%) during the median period of 43 months, with an incident adenoma prevalence of 39.1% and a recurrent adenoma prevalence of 60.1%. An increase in the visceral adipose tissue (VAT) area was associated with a higher incidence of adenoma (highest quintile vs lowest quintile of the VAT hazard ratios [HRs], 2.16; 95% confidence interval [CI], 1.26-3.71; HR 1.32 [per 1-standard deviation]; 95% CI, 1.10-1.60) in the multivariable analysis. Increases in body mass index and waist circumference were associated with recurrent adenomas (HR 1.33 [per 1 kg/m], 95% CI, 1.18-1.46; HR 1.04 [per 1 cm], 95% CI, 1.01-1.07, respectively) in the multivariate analysis.
A higher VAT area was dose-dependently associated with a higher risk of incident adenoma. Furthermore, increases in body mass index and waist circumference as surrogate markers of abdominal obesity were associated with a higher risk of recurrent adenoma.
本研究旨在探讨内脏肥胖与结直肠腺瘤的发生和复发之间的前瞻性关联。
我们进行了一项队列研究,纳入了 2006 年至 2007 年间的 2244 名参与者。根据基线结肠镜检查和组织病理学结果,研究参与者前瞻性随访至 2014 年。新发和复发性结直肠腺瘤组分别定义为基线结肠镜检查中正常结果和腺瘤组中随访结肠镜检查结果阳性的个体。
在接受随访结肠镜检查的 1163 名患者(51.8%)中,509 名(43.8%)和 654 名(56.2%)被分为正常和腺瘤队列。在中位随访 43 个月期间,592 名患者发生结直肠腺瘤(50.9%),新发腺瘤患病率为 39.1%,复发性腺瘤患病率为 60.1%。内脏脂肪组织(VAT)面积的增加与腺瘤的发生率升高相关(VAT 最高五分位与最低五分位的风险比 [HR],2.16;95%置信区间 [CI],1.26-3.71;HR 为 1.32[每 1 个标准差];95%CI,1.10-1.60)。在多变量分析中,体重指数和腰围的增加与复发性腺瘤相关(HR 为 1.33[每 1kg/m],95%CI,1.18-1.46;HR 为 1.04[每 1cm],95%CI,1.01-1.07)。
较高的 VAT 面积与新发腺瘤的风险呈剂量依赖性相关。此外,作为腹部肥胖的替代标志物的体重指数和腰围的增加与复发性腺瘤的风险增加相关。